Restless legs syndrome

Global Restless Legs Syndrome Market and Competitive Landscape 2016-2019 & 2020-2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 14, 2020
General Health, Pharmaceutical, Health, Clinical trials, RTT, Psychiatric diagnosis, Sleep disorders, Restless legs syndrome, Syndromes, Restless, Health, Clinical medicine, Branches of biology

The "Global Restless Legs Syndrome Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Restless Legs Syndrome Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • Global Restless Legs Syndrome Market and Competitive Landscape - 2020, provides comprehensive insights into the Restless Legs Syndrome pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts the Restless Legs Syndrome market size and drug sales.
  • Restless Legs Syndrome pipeline: Find out drugs in clinical trials for the treatment of Restless Legs Syndrome by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Restless Legs Syndrome drugs: Identify key drugs marketed and prescribed for Restless Legs Syndrome in the US, including trade name, molecule name, and company
    Restless Legs Syndrome drugs sales: Find out the sales value for Restless Legs Syndrome drugs by countries
    Restless Legs Syndrome market valuations: Find out the market size for Restless Legs Syndrome drugs in 2019 by countries.

Restless Legs Syndrome Foundation launches new quality of life study

Retrieved on: 
Wednesday, September 23, 2020
Sleep disorders, RTT, Psychiatric diagnosis, Restless legs syndrome, Syndromes, Health, Organ systems, Clinical medicine, RLS, Karl-Axel Ekbom, Periodic limb movement disorder

AUSTIN, Texas, Sept. 23, 2020 /PRNewswire/ --The Restless Legs Syndrome (RLS) Foundation today, international RLS Awareness Day, has launched a research study on the challenges of living with RLS.

Key Points: 
  • AUSTIN, Texas, Sept. 23, 2020 /PRNewswire/ --The Restless Legs Syndrome (RLS) Foundation today, international RLS Awareness Day, has launched a research study on the challenges of living with RLS.
  • This study will provide data to accelerate and focus our efforts to address these challenges and improve quality of life for RLS patients and their families."
  • The RLS Foundation is dedicated to improving the lives of men, women and children who live with restless legs syndrome (RLS, also known as Willis-Ekbom disease).
  • The RLS Foundation Research Grant Program has awarded over $1.8 million to fund medical research on RLS causes and treatments.

Noctrix Health granted FDA Breakthrough Device Designation for wearable Restless Legs Syndrome Therapy

Retrieved on: 
Tuesday, June 2, 2020
Organ systems, Branches of biology, Neurotechnology, Nervous system, Sleep disorders, RTT, Pain, Restless legs syndrome, Syndromes, Neuromodulation, Neurostimulation

SAN FRANCISCO, June 2, 2020 /PRNewswire/ --Noctrix Health, Inc., a privately held medical device company announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its wearable NTX100 Neuromodulation therapy designed for the treatment of adults with primary moderate-severe Restless Legs Syndrome (RLS) who are refractory to medications.

Key Points: 
  • SAN FRANCISCO, June 2, 2020 /PRNewswire/ --Noctrix Health, Inc., a privately held medical device company announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its wearable NTX100 Neuromodulation therapy designed for the treatment of adults with primary moderate-severe Restless Legs Syndrome (RLS) who are refractory to medications.
  • Patients report painful sensations of tingling and an urge to move their feet which particularly worsens during evenings and nights.
  • Noctrix Health aims to treat RLS symptoms with its wearable neuromodulation platform that targets specific peripheral nerve fibers in a manner that is comfortable to wear to sleep.
  • Noctrix Health, Inc. is a pioneer in developing the next generation of wearable therapeutics that employ its neurostimulation platform to treat symptoms of chronic neurological conditions, with an initial focus on sleep disorders.

Restless Leg Syndrome Product Moves to 1st Place in Ratings from TopConsumerReviews.com

Retrieved on: 
Wednesday, December 11, 2019
Sleep disorders, RTT, Psychiatric diagnosis, Restless legs syndrome, Syndromes, RLS, Nervous system, Health, Medicine

For those who experience Restless Leg Syndrome, or RLS, the desire for relief can be all-encompassing.

Key Points: 
  • For those who experience Restless Leg Syndrome, or RLS, the desire for relief can be all-encompassing.
  • This product is affordable and effective, and we're pleased to award Calm Legs our highest ranking among supplements designed to handle Restless Leg Syndrome in 2019."
  • To find out more about Calm Legs and other RLS products, including reviews and comparison rankings, please visit the Restless Leg Syndrome category of TopConsumerReviews.com at https://www.topconsumerreviews.com/restless-leg-syndrome/ .
  • From Restless Leg Syndrome to Blood Pressure and Irritable Bowel Syndrome, TopConsumerReviews.com delivers in-depth product evaluations in order to make purchasing decisions easier.

Restless Legs Syndrome Pipeline Review, H1 2019 Report - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 8, 2019
Health, Pharmaceutical, Psychiatric diagnosis, RTT, Psychiatry, Neurological disorders, Health, Restless legs syndrome, Syndromes, Attention deficit hyperactivity disorder

The "Restless Legs Syndrome - Pipeline Review, H1 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Restless Legs Syndrome - Pipeline Review, H1 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Restless Legs Syndrome - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Restless Legs Syndrome (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
  • The Restless Legs Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Restless Legs Syndrome and features dormant and discontinued projects.
  • The pipeline guide reviews pipeline therapeutics for Restless Legs Syndrome (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

Global Restless Legs Syndrome Market and Competitive Overview 2018: Develop Forecast Models, Healthcare Frameworks & Economic Models

Retrieved on: 
Friday, October 26, 2018
RTT, Psychiatric diagnosis, Sleep disorders, Restless legs syndrome, Syndromes, Restless, Medicine, Neurology, Clinical medicine

Global Restless Legs Syndrome Market and Competitive Landscape - 2018, provides comprehensive insights into Restless Legs Syndrome pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

Key Points: 
  • Global Restless Legs Syndrome Market and Competitive Landscape - 2018, provides comprehensive insights into Restless Legs Syndrome pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.
  • This study accurately estimates and forecast Restless Legs Syndrome market size and drug sales.
  • The research is classified into following sections - Restless Legs Syndrome overview with definitions, symptoms, etiology, diagnosis, treatment options; Restless Legs Syndrome pipeline insights covering late stage clinical trials pipeline; Restless Legs Syndrome prevalence trends by countries; Restless Legs Syndrome market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.
  • Restless Legs Syndrome pipeline: Find out the drugs in clinical trials for Restless Legs Syndrome by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
    Restless Legs Syndrome epidemiology: Find out the prevalence of Restless Legs Syndrome by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
    Restless Legs Syndrome products: Identify key products marketed and prescribed for Restless Legs Syndrome by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
    Restless Legs Syndrome market size: Find out the market size for Restless Legs Syndrome drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
    Restless Legs Syndrome drug sales: Find out the sales of Restless Legs Syndrome drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
    Restless Legs Syndrome drugs sales forecast: Sales forecast for Restless Legs Syndrome drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
    Restless Legs Syndrome market share analysis: Find out the market shares of Restless Legs Syndrome drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
    Did you know that we also offer Custom Research?